Su‐Young Kim

1.1k total citations
47 papers, 722 citations indexed

About

Su‐Young Kim is a scholar working on Dermatology, Immunology and Genetics. According to data from OpenAlex, Su‐Young Kim has authored 47 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Dermatology, 8 papers in Immunology and 6 papers in Genetics. Recurrent topics in Su‐Young Kim's work include Skin Protection and Aging (7 papers), Dermatology and Skin Diseases (5 papers) and Asthma and respiratory diseases (4 papers). Su‐Young Kim is often cited by papers focused on Skin Protection and Aging (7 papers), Dermatology and Skin Diseases (5 papers) and Asthma and respiratory diseases (4 papers). Su‐Young Kim collaborates with scholars based in South Korea, United Kingdom and United States. Su‐Young Kim's co-authors include Dae Yong Yi, Beom Joon Kim, Ro Ra Oh, Won Sang Park, Sang Hyeon Lee, Tae‐Woo Kim, Hyung-In Yang, Yunho Lee, Jae-Dong Lee and Min Sun Shin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Immunology and The Journal of Immunology.

In The Last Decade

Su‐Young Kim

41 papers receiving 700 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Su‐Young Kim 230 94 84 81 80 47 722
Hiroko Nakayama 333 1.4× 66 0.7× 90 1.1× 26 0.3× 79 1.0× 47 915
Dimítrius Leonardo Pitol 179 0.8× 51 0.5× 30 0.4× 54 0.7× 50 0.6× 62 873
Yong‐Dae Kim 385 1.7× 148 1.6× 105 1.3× 55 0.7× 48 0.6× 133 1.2k
Giusy Daniela Albano 269 1.2× 221 2.4× 34 0.4× 40 0.5× 56 0.7× 40 1.1k
Angela Marina Montalbano 370 1.6× 275 2.9× 62 0.7× 50 0.6× 72 0.9× 40 1.3k
Si‐Youn Song 197 0.9× 107 1.1× 67 0.8× 37 0.5× 31 0.4× 76 678
Maciej Chałubiński 161 0.7× 213 2.3× 64 0.8× 43 0.5× 23 0.3× 54 801
Jing Ni 249 1.1× 203 2.2× 83 1.0× 22 0.3× 29 0.4× 68 947
Zhilei Mao 286 1.2× 47 0.5× 71 0.8× 64 0.8× 27 0.3× 34 848
Ertuğrul Kaya 176 0.8× 80 0.9× 86 1.0× 33 0.4× 203 2.5× 78 769

Countries citing papers authored by Su‐Young Kim

Since Specialization
Citations

This map shows the geographic impact of Su‐Young Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Young Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Young Kim more than expected).

Fields of papers citing papers by Su‐Young Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐Young Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Young Kim. The network helps show where Su‐Young Kim may publish in the future.

Co-authorship network of co-authors of Su‐Young Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Su‐Young Kim. A scholar is included among the top collaborators of Su‐Young Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su‐Young Kim. Su‐Young Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saini, Sarbjit S., Marcus Maurer, Grażyna Pulka, et al.. (2025). CTP39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study. Allergy. 80(8). 2167–2177. 10 indexed citations
2.
Grattan, Clive, Grażyna Pulka, Marta Chełmińska, et al.. (2025). Efficacy and safety of CT‐P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16‐week follow‐up study. Clinical and Translational Allergy. 15(6). e70069–e70069.
3.
Hasunuma, Tomoko, Clive Grattan, Takashi Eto, et al.. (2025). Pharmacokinetics and safety of CT‑P39 via auto-injector are comparable to reference omalizumab via pre-filled syringe. Immunotherapy. 17(2). 113–121.
4.
Lee, Jung Ok, Yu-Jin Kim, Dae Ho Yoon, et al.. (2025). Effects of natural killer cell‑conditioned medium on UVB‑induced photoaging in human keratinocytes and a human reconstructed skin model. Molecular Medicine Reports. 31(5). 1–13. 1 indexed citations
5.
Park, Su‐Jin, Su‐Young Kim, Seong‐Hyun Ho, et al.. (2024). Actinidia polygama Water Extract (APWE) Protects Against UVB-Induced Photoaging via MAPK/AP-1 and TGFβ-Smad Pathway. Annals of Dermatology. 36(1). 18–18. 2 indexed citations
6.
Kim, Su‐Young, et al.. (2024). Irisin promotes hair growth and hair cycle transition by activating the GSK‐3β/β‐catenin pathway. Experimental Dermatology. 33(8). e15155–e15155. 7 indexed citations
7.
Park, Hyuna, Jungoh Ahn, Yung‐Hun Yang, et al.. (2023). Production of bio-indigo dye by surmounting its physical and chemical insoluble nature. Dyes and Pigments. 218. 111466–111466. 15 indexed citations
8.
Seok, Joon, Sung‐Dong Cho, Su‐Young Kim, et al.. (2023). A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity. Nature Immunology. 24(8). 1308–1317. 20 indexed citations
9.
Seok, Joon, et al.. (2023). A comparison of dyeing efficacy between hair‐oxidation‐based and hair‐coating‐based shampoos for the treatment of gray hair. Skin Research and Technology. 29(6). e13383–e13383. 1 indexed citations
10.
Maurer, Marcus, Sarbjit S. Saini, Paul A. Wabnitz, et al.. (2022). Pharmacokinetic equivalence of CT‐P39 and reference omalizumab in healthy individuals: A randomised, double‐blind, parallel‐group, Phase 1 trial. Clinical and Translational Allergy. 12(11). e12204–e12204. 9 indexed citations
11.
Kim, Beom Joon, Jungtae Na, Su‐Young Kim, et al.. (2021). Antimicrobial activity of Lactiplantibacillus plantarum APsulloc 331261 and APsulloc 331266 against pathogenic skin microbiota. Frontiers in Bioscience-Elite. 13(2). 237–248. 14 indexed citations
12.
Yi, Dae Yong & Su‐Young Kim. (2021). Human Breast Milk Composition and Function in Human Health: From Nutritional Components to Microbiome and MicroRNAs. Nutrients. 13(9). 3094–3094. 115 indexed citations
13.
Kwon, Tae‐Rin, Sung‐Eun Lee, Jong Hwan Kim, et al.. (2020). 310 nm UV-LEDs attenuate imiquimod-induced psoriasis-like skin lesions in C57BL/6 mice and inhibit IL-22-induced STAT3 expression in HaCaTcells. Photochemical & Photobiological Sciences. 19(8). 1009–1021. 9 indexed citations
14.
Kim, Sunmi, Jangwoo Lee, Jeongim Park, et al.. (2014). Concentrations of phthalate metabolites in breast milk in Korea: Estimating exposure to phthalates and potential risks among breast-fed infants. The Science of The Total Environment. 508. 13–19. 71 indexed citations
15.
Kim, Su‐Young, Sook‐Young Park, Hyejeong Kim, et al.. (2014). Isolation and Characterization of the Colletotrichum acutatum ABC Transporter CaABC1. The Plant Pathology Journal. 30(4). 375–383. 12 indexed citations
16.
Hwang, Se Hwan, Sung Won Kim, Su‐Young Kim, et al.. (2011). Original Article : Human Turbinate Mesenchymal Stromal Cells as a Potential Option for Cartilage Tissue Engineering. 8(6). 536–543. 1 indexed citations
17.
Hwang, Se Hwan, Su‐Young Kim, Sun Hwa Park, et al.. (2011). Original Article : Osteogenic Differentiation of Human Turbinate Mesenchymal Stromal Cells. 8(6). 544–553. 1 indexed citations
18.
Kim, Young Jin, et al.. (2002). A Case of Malignant Eccrine Poroma. Linchuang pifuke zazhi. 40(4). 442–444. 3 indexed citations
19.
Shin, Min Sun, Won Sang Park, Su‐Young Kim, et al.. (1999). Alterations of Fas (Apo-1/CD95) Gene in Cutaneous Malignant Melanoma. American Journal Of Pathology. 154(6). 1785–1791. 105 indexed citations
20.
Shin, Min Sun, Won Sang Park, Su‐Young Kim, et al.. (1999). Immunohistochemical localization of FAP‐1, an inhibitor of Fas‐mediated apoptosis, in normal and neoplastic human tissues. Apmis. 107(7-12). 1101–1108. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026